Dimiter Stanchev Dimitrov

Major research interests are to identify and characterize novel human monoclonal antibodies (mAbs) as candidate therapeutics as well as to develop novel strategies to increase their safety and efficacy.

Evaluating therapeutics antibodies in clinical trials.

Experience

  • –present
    Director, Center for Antibody Therapeutics, University of Pittsburgh

Honours

Chairman’s Gold Medal Recipient, Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Federal Government, 2013

Contact Dimiter for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration